This Multiple sclerosis disease affects the brain and spinal cord. The early symptoms of MS include weakness, tingling, numbness, and blurred vision and other signs are muscle stiffness, thinking problems, and urinary problems. The treatment can relieve the person from MS symptoms and reduce the aggressiveness of the disease progression.

This Multiple Sclerosis is mainly caused by an immune mediated attack targeting components of the myelin sheath. This myelin sheath is known to act as an “insulator” for neurons so that they can communicate properly with each other.

How stem cells help treat multiple sclerosis?

Even though there are so much of advance technologies in the medical industry, still at present there are no treatments that specifically target the abnormal immune responses in MS. The Current approaches to this disease, such as interferon, copaxone, or immune suppressants all act in a non‐specific manner blocking immune responses against the myelin sheath. Since all these approaches are useful for reducing the severity of disease, they do not repair the damage to nervous system tissue that has already occurred and therefore they cannot cure multiple sclerosis.

The mesenchymal stem cells have the quality of immune regulatory properties which may stop the immune system from attacking the myelin sheath.

These mesenchymal stem cells also have the potential to help remyelination (re-generation of the myelin sheath) of the affected neurons. Recently the University of Cambridge is conducting formal clinical studies using mesenchymal stem cells for treatment of MS.

We have observed improvements in multiple sclerosis patients treated at our facilities, through administration of umbilical cord tissue-derived mesenchymal stem cells.

Types of stem cells that are used to treat multiple sclerosis and how are they collected.

The adult stem cells that come from the Stem Cell Institute from human umbilical cord tissue are used to treat MS. Thesesmesenchymal stem cells that are used are recovered from donated umbilical cords following normal, healthy births. Every single mother has her medical history screened and is tested for infectious diseases. Prior to donation proper consent is received from each family

All umbilical cord-derived stem cells before they are cleared for use in patients; they are screened for infectious diseases to International Blood Bank Standards.